| Test |
time |
n |
Mean |
SE |
| Knee pain VAS -DA(0-100) |
0 |
50 |
57 |
22 |
| |
12 months |
50 |
23 |
21 |
| Knee pain VAS- Sp (0-100) |
0 |
32 |
74 |
17 |
| |
12 months |
32 |
28 |
22 |
| WOMAC (0-100) |
|
|
|
|
| Pain subscale |
0 |
50 |
6 |
3 |
| |
12 months |
50 |
3 |
2.5 |
| Rigidity subscale |
0 |
50 |
2.2 |
1.3. |
| |
12 months |
50 |
0.9 |
1.1 |
| Function loss subscale |
0 |
50 |
18 |
8.8 |
| |
12 months |
50 |
10 |
7.8 |
| Total WOMAC scale |
0 |
50 |
27.15 |
11.9 |
| |
12 months |
50 |
15.14 |
10.8 |
| Lequesne (0-100) |
0 |
50 |
10.9 |
4.9 |
| |
12 months |
50 |
5.2 |
4.1 |
|
| In all cases, the scale was from 0 to 100%. Measurements were performed beforecell transplantation (0) and 12 months afterwards.; VAS-DA, Visual AnalogueScale for pain associated to daily activities; VAS-SP, Visual Analogue Scale forpain associated to sports activities; WOMAC, Western Ontario and McMasterUniversities Osteoarthritis Index. |
| Table 1: Total score sum of VAS, WOMAC, and Lequesne severity indices. |
